Most CEOs believe they make decisions through logic — that strategy, data, and experience lead the process. But every decision begins in a body and brain already biased by what came before. The confidence you feel in a boardroom, the urgency that drives a new initiative, or the fatigue that blunts your focus at the end of a quarter — none of these start at zero. Each moment carries the residue of chemistry: the reward of what went right, the relief of what avoided pain, and the tension of what remains unresolved.
This repeating pattern — the one that makes conviction feel certain and hesitation feel wrong — is what we call the Neurochemical Decision Cycle. It unfolds in three stages: Decision-Making, Daily Execution, and Recovery & Rest.
These stages are not isolated moments. Each one shapes the next. The dopamine that rewards progress in one phase becomes overconfidence in the next. The cortisol that keeps you alert under pressure becomes over-vigilance when pressure ends. And by the time you reach a new decision, you’re already carrying the chemical momentum of the last one.
The Architecture of the Cycle
Imagine every major choice — a strategy pivot, a new hire, a market entry — as part of a living system that constantly loops between action and recovery. In one phase, you decide. In the next, you execute. In the final phase, you recover — or fail to. When this system runs unconsciously, chemistry decides before logic speaks. When you learn to regulate it, clarity compounds instead of distortion. The key is recognising the forces that drive it: reward-driven momentum and avoidance under discomfort.
Stage 1 — Decision-Making
Where conviction feels rational long before it is.
Decision-making is the most visible stage, but it’s rarely the most conscious. Long before a strategy feels “right,” the brain has already rewarded it with dopamine for fitting a familiar pattern. The surge of relief, confidence, or alignment feels like logic — but it’s chemistry. That’s Reward-Driven Momentum, the Dopamine Feedback Loop. When an idea matches what you hope to be true, the mind releases dopamine, and suddenly conviction forms faster than validation. You start building around the sense of correctness rather than around the evidence itself.
At the same time, another loop operates quietly in the background: Avoidance Under Discomfort, the Cortisol Feedback Loop. When contradiction appears — a red flag in the data, a concern from a board member — it produces a flicker of tension. The brain interprets that discomfort as a problem to remove. So it rationalises, reframes, or moves on. The relief that follows feels like clarity, and the loop repeats. Over time, momentum and avoidance reinforce each other: dopamine accelerates conviction, cortisol drives the urge to rationalise and move past friction, and the decision feels balanced even when it isn’t.
This is why smart leaders sometimes stay committed to flawed directions long after logic should intervene. The conviction is real — it’s just chemically produced. Learning to recognise that early surge of “rightness,” and to pause before it becomes policy, is the beginning of precision.
Stage 2 — Daily Execution
Where focus, consistency, and resistance collide.
Once a decision is made, chemistry doesn’t stop; it simply changes shape. In execution, dopamine drives energy toward what feels rewarding, while cortisol pulls attention away from what feels heavy. The result is a day full of motion — but not always of progress.
When dopamine leads, you experience Reward-Driven Activity, the Dopamine Feedback Loop again, this time through activity. A new idea, positive feedback, or a quick win releases dopamine and re-orders your priorities on the spot. You feel a rush of progress and dive in. Work that lacks stimulation — strategy, follow-through, difficult conversations — quietly slides down the list. You tell yourself you’re being adaptive, but in reality, you’re being steered by chemistry, not by importance.
Meanwhile, cortisol is shaping a parallel story. It introduces Avoidance-Driven Resistance, the Cortisol Feedback Loop, into your workflow. Every leader knows the moment: the complex task that suddenly feels tiring, the ambiguous project that “needs more input,” the proposal you’ll “get to later.” The act of switching to easier work brings relief, and that relief reinforces the behaviour. Avoidance starts to look like prioritisation. You stay busy, and the day feels productive — yet the work that matters most moves only when pressure, not clarity, finally forces it forward.
Awareness of these loops doesn’t mean suppressing energy or erasing emotion. It means noticing when your sense of progress is being chemically engineered. When you can tell the difference between real advancement and the feeling of advancement, execution stops drifting and starts compounding.
Stage 3 — Recovery & Rest
Where the next decision quietly begins.
For many CEOs, this is the invisible stage — the one that determines whether tomorrow starts from clarity or from residue. After the intensity of decision and execution, the body is meant to reset. Yet dopamine and cortisol often keep the system running long after the workday ends.
The Reward-Driven Continuation, the Dopamine Feedback Loop, keeps the mind attached to what was just finished. You close the laptop, but your thoughts stay locked on the previous project — refining, replaying, perfecting. The same drive that enabled deep focus now blocks transition. The chemistry of engagement refuses to release.
At the same time, Alertness After Completion, the Cortisol Feedback Loop stays active. The body remains slightly tense, the mind keeps scanning for unresolved risks, and even rest feels conditional: “I’ll relax once this is done.” But it often doesn’t feel done, because the system doesn’t recognise safety unless it’s explicitly told to. You lie awake replaying the day, believing you’re thinking productively, when in fact your nervous system is still working off yesterday’s chemistry.
This incomplete reset is why performance sometimes plateaus even in high-functioning leaders. It’s not a failure of discipline; it’s biology. The next morning begins from a biased baseline — momentum and vigilance inherited rather than chosen. True recovery isn’t leisure; it’s the deliberate act of returning the system to neutral so that the next cycle starts clean.
Regulating the Cycle
The Neurochemical Decision Cycle isn’t a flaw — it’s the operating system that enables both conviction and resilience. The problem arises when it runs on autopilot. When you regulate it consciously, dopamine becomes a source of drive rather than distortion, and cortisol becomes a signal to focus rather than a cue to avoid. Each stage then performs its true function: decisions grounded in clarity, execution aligned with strategy, recovery that actually restores.
You don’t need to dismantle instinct or emotion. You just need to know when chemistry is steering logic instead of supporting it. The goal is not neutrality for its own sake, but precision — the ability to decide, act, and recover from a balanced baseline rather than from inherited bias.
See Your Own Cycle
Every leader’s chemistry has a pattern. Once it’s mapped, it becomes visible in every decision, project, and recovery habit you have. The Decision Excellence Assessment reveals that a map — showing how dopamine and cortisol shape your logic across Decision-Making, Daily Execution, and Recovery & Rest.
If you’d like to see where chemistry is leading logic in your own cycle, you can take the assessment and receive your personalised 29-page Decision Excellence Score Report.
Tomasz Drybala – Author, Researcher, Coach, and Director of the Neuro-Based Leadership Centre
My work is grounded in lived experience, research, and ongoing studies with more than 100 CEOs and senior executives — examining how dopamine–cortisol dynamics influence decision-making, execution, and recovery under pressure.
My academic development now includes targeted programs at Harvard, Cambridge, Oxford, and the University of California, Berkeley. I am pursuing a Master’s and — fingers crossed — a PhD in Applied Neuroscience, specialising in decision-making.
I’m also the author of three forthcoming books exploring the neurochemistry of leadership, including Breaking Patterns (September 2026), Neuroscience of CEO Decision-Making (January 2027), and Choosing the Right People (March 2027).